Oculis Holding AG (OCS)
12.94
-0.24
(-1.78%)
USD |
NASDAQ |
Aug 25, 16:00
12.94
0.00 (0.00%)
After-Hours: 19:59
Oculis Shareholders Equity (Quarterly) : 271.91M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 271.91M |
| March 31, 2026 | 244.72M |
| December 31, 2025 | 247.48M |
| September 30, 2025 | 164.14M |
| June 30, 2025 | 179.77M |
| March 31, 2025 | 183.81M |
| December 31, 2024 | 80.97M |
| September 30, 2024 | 112.89M |
| June 30, 2024 | 125.56M |
| March 31, 2024 | 87.75M |
| December 31, 2023 | 111.36M |
| Date | Value |
|---|---|
| September 30, 2023 | 115.44M |
| June 30, 2023 | 131.00M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 120.86M |
| September 30, 2021 | 121.31M |
| June 30, 2021 | 120.11M |
| March 31, 2021 | 112.64M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 41.54B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 4.087M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 310.34M |
| Total Liabilities (Quarterly) | 38.43M |
| Debt to Equity Ratio | 0.0116 |
| Current Ratio | 8.347 |
| Net Debt Paydown Yield | -0.04% |